Sexually Transmitted Disease (STD) Self-Testing Market Report 2026

Sexually Transmitted Disease (STD) Self-Testing Market Overview

• Sexually Transmitted Disease (STD) Self-Testing market size has reached to $1.52 billion in 2025 • Expected to grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: The Rising Incidence Of Syphilis Is Fueling The Growth Of The Market Due To Its Role In Driving Demand For Private And Early Self-Testing Solutions • Market Trend: Advancement Of At-Home STD Self-Testing Through FDA-Approved OTC Collection Kits • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sexually Transmitted Disease (STD) Self-Testing Market?

Sexually transmitted disease (STD) self-testing refers to the process where individuals collect their own samples to test for STDs outside of a clinical setting. This method allows for private, convenient, and timely detection of infections such as chlamydia, gonorrhea, HIV, or syphilis using at-home kits or mail-in lab services. The main types of sexually transmitted disease (STD) self-testing samples are blood-based tests, urine-based tests, and oral-based tests. A blood-based STD self-test uses a small blood sample, typically from a finger prick, to accurately detect infections like HIV, syphilis, and hepatitis at early stages. It is distributed through various distribution channels such as hospital pharmacies, online pharmacies, and retail pharmacies for several applications, including chlamydia trachomatis (CT) or Neisseria gonorrhoeae (NG) testing, syphilis testing, human immunodeficiency virus (HIV) testing, and others.

What Is The Sexually Transmitted Disease (STD) Self-Testing Market Growth Forecast?

The sexually transmitted disease (std) self-testing market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to adoption of digital health platforms, integration of multi-sample at-home testing kits, rising government awareness campaigns, increasing telehealth consultations, development of rapid and accurate diagnostic technologies. Major trends in the forecast period include rising demand for at-home std testing kits, increasing awareness of sexual health and early diagnosis, growth in telehealth and remote consultation services, expansion of online and retail pharmacy distribution channels, integration of multi-sample testing solutions (blood, urine, oral).

Global Sexually Transmitted Disease (STD) Self-Testing Market Segmentation

1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test 2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies 3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications Subsegments: 1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device 2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection 3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection

What Is The Driver Of The Sexually Transmitted Disease (STD) Self-Testing Market?

The rising incidence of syphilis is expected to propel the growth of the sexually transmitted disease (STD) self-testing market going forward. Syphilis is a sexually transmitted infection that causes sores on the body and can lead to serious health problems if not treated. Syphilis is increasing due to a decline in consistent condom use, particularly among populations engaging in high-risk sexual behaviors. STD self-testing enables private and convenient at-home screening for syphilis, promoting early diagnosis. This early detection ensures prompt treatment, minimizing complications and preventing further spread. For instance, in September 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, around 209,253 syphilis cases were reported in 2023, representing a 1% increase from 207,269 cases in 2022. Therefore, the rising incidence of syphilis is driving the growth of the sexually transmitted disease (STD) self-testing industry.

Key Players In The Global Sexually Transmitted Disease (STD) Self-Testing Market

Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

Global Sexually Transmitted Disease (STD) Self-Testing Market Trends and Insights

Major companies operating in the STD self-testing market are focusing on developing advanced products, such as over-the-counter (OTC) sample collection kits, to promote early detection and timely treatment of infections. Over-the-counter sample collection kits are at-home diagnostic tools that let individuals collect samples such as urine or swabs without needing a prescription. They provide a convenient and confidential way to detect infections early and enable prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, launched the CheckMeSafe home collection kit for HIV and syphilis testing. It is an FDA-approved kit that allows individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own home. Users can mail their samples to the lab using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit provides highly accurate results, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are analyzed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.

What Are Latest Mergers And Acquisitions In The Sexually Transmitted Disease (STD) Self-Testing Market?

In December 2024, OraSure Technologies Inc., a US-based provider of point-of-need and home diagnostic tests and sample management solutions, acquired Sherlock Biosciences for an undisclosed amount. With this acquisition, OraSure Technologies aims to strengthen its position in the at-home diagnostics market by integrating Sherlock Biosciences’ advanced CRISPR-based molecular technology to develop rapid, over-the-counter self-tests for sexually transmitted infections like chlamydia and gonorrhea, enabling users to receive lab-quality results at home within minutes and expanding access to accurate, private STD testing. Sherlock Biosciences is a US-based company that provides clinical trials for rapid OTC diagnostics for STIs.

Regional Insights

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sexually Transmitted Disease (STD) Self-Testing Market?

The sexually transmitted disease (STD) self-testing market consists of revenues earned by entities by providing services such as telehealth consultations, digital result delivery, follow-up care coordination, and online pre-test counselling. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted disease (STD) self-testing market includes sales of sample collection devices, buffer solutions or reagents, at-home diagnostic kits, mobile app-based test tracking tools, and smartphone-compatible test devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sexually Transmitted Disease (STD) Self-Testing Market Report 2026?

The sexually transmitted disease (std) self-testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted disease (std) self-testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.